New Delhi, Mar 29 (PTI) HealthCare Global Enterprises (HCG) has entered into definitive agreements to acquire a majority stake in Cancer Care Kenya for an undisclosed amount. Also Read - Coronavirus: In First Public Statement, Boris Johnson Says 'Owe my Life to NHS Staff' The UK government’s development finance institution CDC and MP Shah Hospital, a tertiary care hospital in Kenya, will also participate in the transaction, HealthCare Global Enterprises said in a filing to BSE. Also Read - Coronavirus: Ailing British PM Boris Johnson Taking 'Short Walks,' His Office Says The company, however, did not disclose any financial details about the proposed acquisition. Also Read - Coronavirus: Boris Johnson's Condition Improves, Moved Out of Intensive Care The founder of Cancer Care Kenya (CCK) N Adamali will retain his shareholding in the company post acquisition and will continue his association, it added. CCK, which started operation in 2010, is the first private comprehensive cancer centre in Kenya. The company is excited by the opportunity to partner with CCK and looks forward to working closely with our partners, Dr Adamali, CDC and MP Shah Hospital to bring in the highest standards of excellence in cancer care in Africa…, HCG Chairman B S Ajaikumar said. Shares of HealthCare Global Enterprises today closed at Rs 228.75 per scrip on BSE, up 0.99 per cent from its previous close. This is published unedited from the PTI feed.
HealthCare healthcare Enterprises ( HCG ) will acquire a majority stake in Cancer Care Kenya for an unknown amount . The acquisition will also include the hospital , the UK government healthcare finance institution , and mater Shah Hospital , a tertiary care facility in jersey .